sb 203580 has been researched along with ku 55933 in 3 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (ku 55933) | Trials (ku 55933) | Recent Studies (post-2010) (ku 55933) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 164 | 0 | 127 |
| Protein | Taxonomy | sb 203580 (IC50) | ku 55933 (IC50) |
|---|---|---|---|
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Homo sapiens (human) | 0.458 | |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Homo sapiens (human) | 0.133 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 7.44 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.4943 | |
| Serine-protein kinase ATM | Homo sapiens (human) | 0.191 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Kowluru, A; Sidarala, V | 1 |
| Li, Y; Wang, Y; Yang, L; Yin, D | 1 |
3 other study(ies) available for sb 203580 and ku 55933
| Article | Year |
|---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
Exposure to chronic hyperglycemic conditions results in Ras-related C3 botulinum toxin substrate 1 (Rac1)-mediated activation of p53 and ATM kinase in pancreatic β-cells.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Imidazoles; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Morpholines; p38 Mitogen-Activated Protein Kinases; Prenylation; Pyridines; Pyrones; Quinolines; rac1 GTP-Binding Protein; Rats; Simvastatin; Tumor Suppressor Protein p53 | 2017 |
Intermittent low dose irradiation enhances the effectiveness of radio- and chemo-therapy for human colorectal adenocarcinoma cell line HT-29.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Ataxia Telangiectasia Mutated Proteins; Benzothiazoles; Cell Proliferation; Chemoradiotherapy; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fluorouracil; HT29 Cells; Humans; Imidazoles; MAP Kinase Signaling System; Morpholines; p38 Mitogen-Activated Protein Kinases; Pyridines; Pyrones; Radiation Dosage; Toluene; Tumor Suppressor Protein p53 | 2017 |